H.-J. Gais et al. / Tetrahedron: Asymmetry 9 (1998) 235–248
245
5.86 (dq, J=15.5, J=6.2, 1H); 13C NMR (75 MHz, CDCl3) δ 11.13 (d), 13.06 (d), 13.57 (d), 19.95 (u),
21.86 (u), 23.48 (u), 25.74 (u), 49.06 (u), 67.76 (d), 121.98 (d), 141.51 (d); GC–MS (EI, 70 eV) m/z (rel.
intensity) 217 (M+, 1), 123 (100), 97 (20), 81 (5), 65 (1), 55 (9), 53 (4), 41 (5), 39 (15).
4.12. (−)-(S)-3-(tert-Butylsulfonyl)cyclopent-1-ene 15a
A mixture of rac-14a (0.13 g, 0.93 mmol), Pd2(dba)3·CHCl3 (15 mg, 14 µmol) and 12 (31 mg, 45
µmol) in CH2Cl2 (3 mL) was stirred for 30 min at room temperature. The yellow solution was cooled
to 0°C and a cold (0°C) suspension of LiO2St-Bu (256 mg, 2 mmol) and Hex4NBr (24 mg, 55.2 µmol)
in CH2Cl2 (3 mL) was added. Subsequently, water (3 mL) was added quickly to the mixture. After
stirring the reaction mixture for 1 day at room temperature, brine (10 mL) was added and the mixture
was stirred for 1 h. The aqueous phase was extracted with CH2Cl2, and the combined organic phases
were concentrated in vacuum. Purification of the residue by chromatography (n-hexane:EtOAc:NEt3,
13:76:1) gave 15a (133 mg, 76%) as a colorless solid: 89% ee [GC, Lipodex-E: tR (15a)=33.62, tR (ent-
1
15a)=33.75; H NMR (300 MHz, CDCl3, 30 mol% Eu(hfc)3): δ (t-Bu) (15a) 2.47, δ (t-Bu) (ent-15a)
22
2.50]; mp 58°C; [α]D −192.6 (c 1.02, CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 1.44 (s, 9H), 2.16–2.75
(m, 4H), 4.40 (m, 1H), 5.78–5.83 (ddt, J=5.7, J=2.3, J=2.0, 1H), 6.19–6.23 (ddt, J=5.7, J=2.0, J=1.3,
1H); 13C NMR (75 MHz, CDCl3) δ 24.16 (d), 25.99 (u), 32.69 (u), 60.15 (u), 64.73 (d), 123.85 (d),
139.18 (d); MS (EI, 70 eV) m/z (rel. intensity) 67 (M+−SO2t-Bu, 100), 66 (20), 57 (78); IR (KBr) ν
3327 (w), 3085 (w), 3057 (m), 2973 (s), 2933 (s), 2854 (m), 1627 (m), 1577 (w), 1479 (s), 1465 (s), 1398
(m), 1372 (m), 1352 (m), 1278 (s), 1196 (m), 1107 (s), 1014 (s), 988 (m), 942 (w), 917 (s), 805 (m), 742
(s), 671 (s), 616 (s) cm−1. Anal. Calcd for C9H16O2S: C, 57.41; H, 8.57. Found: C, 57.36; H, 8.76.
4.13. (−)-(S)-3-(tert-Butylsulfonyl)-cyclohex-1-ene 15b
Following the procedure described for the synthesis of 15a, rac-14b (0.80 g, 5.1 mmol),
Pd2(dba)3·CHCl3 (75 mg, 72.4 µmol), 12 (155 mg, 0.22 mmol), LiO2St-Bu (1.3 g, 10 mmol)
and Hex4NBr (125 mg, 0.3 mmol) in CH2Cl2 (60 mL) and water (30 mL) gave, after 1 h at 0°C and 2
h at room temperature, 15b (0.97 g, 92%) as a colorless solid: 90% ee [1H NMR (300 MHz, CDCl3, 30
22
mol% Eu(hfc)3): δ (t-Bu) (15b) 2.08, δ (t-Bu) (ent-15b) 2.12]; mp 55°C; [α]D −170 (c 0.99, CH2Cl2);
1H NMR (300 MHz, CDCl3) δ 1.45 (s, 9H), 1.58–1.70 (m, 1H), 1.94–2.28 (m, 5H), 3.93 (m, 1H), 5.84
(ddt, J=10.4, J=4.0, J=2.0, 1H), 6.12 (ddt, J=10.4, J=4.0, J=2.3, 1H); 13C NMR (75 MHz, CDCl3) δ
20.14 (u), 23.90 (u), 24.28 (d), 24.37 (u), 55.23 (d), 61.27 (u), 119.75 (d), 134.64 (d); MS (EI, 70 eV)
m/z (rel. intensity) 81 (M+−SO2t-Bu, 34), 80 (29), 79 (23), 77 (10), 57 (100), 53 (11); IR (KBr) ν 3392
(m), 3042 (m), 2981 (st), 2943 (st), 2921 (st), 2870 (m), 2839 (m), 1676 (w), 1647 (w), 1589 (w), 1471
(s), 1449 (m), 1433 (m), 1397 (m), 1385 (m), 1370 (m), 1364 (m), 1331 (m), 1283 (s), 1249 (s), 1242
(s), 1210 (s), 1188 (s), 1112 (s), 1044 (m), 1022 (m), 991 (m), 946 (w), 935 (m), 896 (s), 871 (m), 835
(m), 801 (m), 762 (m), 746 (m), 736 (m), 717 (m), 675 (s), 628 (s) cm−1. Anal. Calcd for C10H18O2S:
C, 59.37; H, 8.97. Found: C, 59.10; H, 9.01.
4.14. (−)-(S)-3-(tert-Butylsulfonyl)-cyclohept-1-ene 15c
Following the procedure described for the synthesis of 15a, rac-14c (172 mg, 1 mmol),
Pd2(dba)3·CHCl3 (15.5 mg, 15 µmol), 12 (31.3 mg, 45 µmol), LiO2St-Bu (256 mg, 2 mmol)
and Hex4NBr (25 mg, 57.5 µmol) in CH2Cl2 (6 mL) and water (3 mL) gave, after 2 h, 15c (192 mg,
1
89%) as a colorless solid: 93% ee [GC, Lipodex-E: tR (15c)=33.84, tR (ent-15c)=34.20; H NMR (300